Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); Solid FQ2 Results Make Us Modestly More Positive
Tweet Send to a Friend
Canaccord Genuity maintains a 'Hold' on AngioDynamics (NASDAQ: ANGO), raises PT to $17.
Canaccord analyst says, "FQ2/11 (Nov) results showed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "FQ2/11 (Nov) results showed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
